4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001209191-23-016783
SVP, CFO acquired 1,583 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Daphne SVP, CFO | 2023-03-04 | Option exercise | +1,583 | 5,423 | D | ||
| Derivatives | |||||||
| Taylor Daphne SVP, CFO | 2023-03-03 | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | D | ||
| Taylor Daphne SVP, CFO | 2023-03-03 | Grant or award · Restricted Stock Unit | +11,000 | 11,000 | D | ||
| Taylor Daphne SVP, CFO | 2023-03-04 | Option exercise · Restricted Stock Unit | −1,583 | 3,167 | D | ||
Loading xslF345X03/doc4.xml…